Rules and Regulations. DEPARTMENT OF HEALTH AND HUMAN SERVICES

451 words·~2 min read·/register/2020/01/28/2020-01384

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Allergy and Infectious Diseases Special Emphasis Panel;

HHS-NIH-CDC-SBIR PHS 2020-1: Co-Delivery and Formulation of Adjuvants for HIV Vaccine Development (Topic 76) and Particle-based Co-delivery of HIV Immunogens as Next-generation HIV Vaccines (Topic 77). *Date:* February 19-21, 2020. *Time:* 11:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). *Contact Person:* Mario Cerritelli, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC-9823, Rockville, MD 20852, 240-669-5199, *cerritem@mail.nih.gov.* *Name of Committee:* National Institute of Allergy and Infectious Diseases Special Emphasis Panel;

HHS-NIH-CDC SBIR PHS 2020-1 Topic 84: Antiviral Drugs to Cure Chronic Hepatitis B Virus Infection. *Date:* February 20-21, 2020. *Time:* 11:00 a.m. to 4:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). *Contact Person:* Yong Gao, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room #3G13B, MSC 9823, Rockville, MD 20892-7616,

(240)669-5048, *gaoL2@niaid.nih.gov.* *Name of Committee:* National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS-NIH-CDC SBIR PHS 2020-1 Topic 82: Production of Adjuvants. *Date:* February 21, 2020. *Time:* 12:00 p.m. to 4:00 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). *Contact Person:* Yong Gao, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room #3G13B, MSC 9823, Rockville, MD 20892-7616,

(240)669-5048, *gaoL2@niaid.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 22, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020-01384 Filed 1-27-20; 8:45 am]